Dapagliflozin for treating chronic kidney disease
NICE suggest that (1):
Study evidence supporting use of dapagliflozin for chronic kidney disease comes from the DAPA-CKD trial where (2,3):
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page